Organisation paid for research Program year 2020 Source: CMS Open Payments

FXM Research Corp

Neither a doctor nor a teaching hospital

Research payments

$300,475

29 payments

Through program year 2020, FXM Research Corp is reported as receiving $300,475 in research payments, across 29 payments.

By program year

2 rows
Year Kind Amount Payments
2020 Research $10,675 1
2019 Research $289,800 28

Breakdown

Who paid Research payments · program years 2019–2020
  1. Taro Pharmaceuticals USA, Inc. $283,750 25 payments
  2. Dr.Reddy's Laboratories,Inc. $16,725 4 payments
Studies the money was for Research payments · program years 2019–2020
  1. To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15 Topical Gel $53,685 2 payments
  2. Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris $53,385 7 payments
  3. Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris $52,010 3 payments
  4. Adbg 1908 $47,775 4 payments
  5. DXPN 1807 $41,850 2 payments
  6. BTCG 1808 $18,150 2 payments
  7. Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis $16,725 4 payments
  8. An Open-Label Study to Assess the Efficacy and Potential for Adrenal Suppression Following Maximal Use Treatment With TA-102 Topical Formulations in Subjects With Plaque Psoriasis $10,675 1 payment
  9. An Open-Label Study to Assess Safety $5,220 3 payments
  10. CTBC 1705 $1,000 1 payment
What the money was spent on Research payments · program years 2019–2020
  1. Professional salary support $256,700 19 payments
  2. Other $24,050 5 payments
  3. Overhead $3,000 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record